Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Zymeworks Inc. Director's Dealing 2023

Dec 8, 2023

32180_dirs_2023-12-08_32b61561-d94b-4587-afab-82481ea605b4.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Zymeworks Inc. (ZYME)
CIK: 0001937653
Period of Report: 2023-12-07

Reporting Person: Davidson Nancy (N/A)

Holdings (Non-Derivative)

Security Shares Ownership
No securities are beneficially owned 0 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
No securities are beneficially owned $ Not applicable (0) Direct

Footnotes

F1: Not applicable.